Sitagliptin - CISMeF

Preferred Label : Sitagliptin;

NCIt definition : An orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis.;

UNII : QFP0P1DV7Z;

InChIKey : MFFMDFFZMYYVKS-SECBINFHSA-N;

CAS number : 486460-32-6;

Chemical formula : C16H15F6N5O;

ChEBI ID : CHEBI:40237;

Codes from synonyms : 120762;

Détails

Origin ID

C73838;

UMLS CUI

C1565750;

Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing sitagliptin (medicinal product) [SNOMED CT concept]
- Sitagliptin (substance) [SNOMED CT concept]
- sitagliptin [ATC Code]
- sitagliptin [MeSH concept]
Validated automatic mappings to BTNT
- Sitagliptin Phosphate [MeSH Descriptor]
- sitagliptin [ATC Code]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]
has_salt_form
- Sitagliptin Phosphate [NCIt concept]
has_target
- Dipeptidyl Peptidase 4 [NCIt concept]
is_free_acid_or_base_form_of
- Sitagliptin Phosphate [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients